Cocrystal Pharma (COCP) Current Assets (2010 - 2026)
Cocrystal Pharma (COCP) posted Current Assets of $5.9 million for Q1 2026, down 26.99% sequentially from $8.1 million in Q4 2025, and down 32.71% YoY from $8.8 million in Q1 2025.
Cocrystal Pharma (COCP) Current Assets (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Current Assets for 16 years, with the latest figure at $5.9 million in Q1 2026.
- Quarterly Current Assets fell 32.71% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 32.71% YoY) and the FY2025 annual result came in at $8.1 million, down 29.76% from the prior year.
- Current Assets fell to $5.9 million in Q1 2026 per COCP's latest filing, from $8.1 million in the prior quarter.
- Over five years, Current Assets peaked at $55.4 million in Q1 2022 and troughed at $5.9 million in Q1 2026.
- A 5-year average of $25.6 million and a median of $24.5 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets soared 64.43% in 2022, then plunged 65.59% in 2025.
- Over 5 years, Current Assets stood at $40.2 million in 2022, then declined by 27.59% to $29.1 million in 2023, then slumped by 60.19% to $11.6 million in 2024, then slipped by 29.76% to $8.1 million in 2025, then decreased by 26.99% to $5.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $5.9 million, $8.1 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 1.76 Bn |
| 10 | Cocrystal Pharma | 16.06 Mn | 13.74 Mn | - | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Mar 31, 2026 | 5.94 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.78 Mn |
| Jun 30, 2025 | 6.77 Mn |
| Mar 31, 2025 | 8.83 Mn |
| Dec 31, 2024 | 11.58 Mn |
| Sep 30, 2024 | 14.26 Mn |
| Jun 30, 2024 | 19.66 Mn |
| Mar 31, 2024 | 24.49 Mn |
| Dec 31, 2023 | 29.09 Mn |
| Sep 30, 2023 | 32.21 Mn |
| Jun 30, 2023 | 35.76 Mn |
| Mar 31, 2023 | 37.24 Mn |
| Dec 31, 2022 | 40.18 Mn |
| Sep 30, 2022 | 44.90 Mn |
| Jun 30, 2022 | 51.60 Mn |
| Mar 31, 2022 | 55.40 Mn |
| Dec 31, 2021 | 59.32 Mn |
| Sep 30, 2021 | 62.44 Mn |